Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest Live attenuated influenza vaccine Stories

2012-10-19 15:22:42

GAITHERSBURG, Md., Oct. 19, 2012 /PRNewswire/ -- MedImmune, the global biologics arm of AstraZeneca, announced today it will present three influenza abstracts at IDWeek 2012: the first combined meeting of the Infectious Diseases Society of America, the Society for Healthcare Epidemiology of America, the HIV Medicine Association, and the Pediatric Infectious Diseases Society, in San Diego, California, October 17-21, 2012. These abstracts expand upon the existing body of knowledge and data...

2012-10-09 11:28:21

GAITHERSBURG, Md., Oct. 9, 2012 /PRNewswire/ -- MedImmune, the global biologics arm of AstraZeneca, announced today it will present four abstracts at the Influenza Vaccines for the World (IVW) International Conference at the Palacio de Congresos de Valencia, Valencia, Spain, October 9-12, 2012. These abstracts advance the body of existing data and knowledge surrounding influenza vaccination, highlighting MedImmune's continued leadership in helping to improve patient health. MedImmune...

2012-10-01 20:25:13

Research published in the journal Genetics may lead to more protective flu vaccines by helping developers more accurately predict strains most likely to strike the population in the coming season With flu season around the corner, getting a seasonal vaccine might be one of the best ways to prevent people from getting sick. These vaccines only work, however, if their developers have accurately predicted which strains of the virus are likely to be active in the coming season because vaccines...

2012-03-26 06:29:51

GAITHERSBURG, Md., March 26, 2012 /PRNewswire/ -- MedImmune announced today it will present nine abstracts at the National Immunization Conference Online (NIC Online), from March 26 - 28, 2012. This is the first virtual conference, where presenters and attendees will participate in live or archived sessions entirely online. MedImmune is presenting new research on pediatric influenza vaccination and the safety and efficacy of live attenuated influenza vaccine. This research reinforces...

2011-07-18 05:00:00

GAITHERSBURG, Md., July 18, 2011 /PRNewswire/ -- MedImmune has received confirmation from the U.S. Food & Drug Administration (FDA) that the Agency has filed the Company's supplemental Biologics License Application (sBLA) for a quadrivalent (four-strain) version of FluMist® (Influenza Vaccine Live, Intranasal). The company submitted the sBLA early in the second quarter of this year. Currently licensed seasonal influenza vaccines are trivalent, containing three strains...

2011-03-29 09:25:00

WASHINGTON, March 29, 2011 /PRNewswire/ -- MedImmune announced today it will present a total of 11 abstracts at the 45th National Immunization Conference (NIC) at the Washington Hilton in Washington, DC, March 28 - 31, 2011. These abstracts advance the body of existing data and knowledge surrounding influenza prevention and trends in vaccination, highlighting MedImmune's strong leadership in patient health in various medical settings. "MedImmune is pleased to announce new research on...

2010-04-19 11:00:00

ATLANTA, April 19 /PRNewswire/ -- MedImmune announced today it will present 10 abstracts at the National Immunization Conference (NIC), all of which add to the company's growing body of research regarding pediatric infectious disease prevention. "With the growing importance of influenza prevention, it is essential to better understand the current data on influenza vaccines as well as how best to provide them to children and adults in the United States," said Alexander A. Zukiwski, M.D.,...

2010-01-13 08:00:00

VIENNA, Austria, January 13 /PRNewswire/ -- - By Starting the Phase II Study for deltaFLU, AVIR Green Hills AG has Accomplished yet Another Milestone in the Development of this Novel Influenza Vaccine. Completion of this Clinical Phase II Study is Envisaged for Spring 2010 - The Positive Results Obtained in the Previous Clinical Phase I Study will be Published in the Renowned "Journal of Infectious Diseases" on 15 January 2010 AVIR Green Hills Biotechnology, the innovative...

2009-10-30 18:05:09

MedImmune announced today it will present four abstracts at the 47th Annual Meeting of Infectious Disease Society of America (IDSA) being held here October 29 through November 1, 2009. These abstracts advance the body of data surrounding respiratory syncytial virus (RSV) and influenza prevention, highlighting MedImmune's leadership in pediatric health. "MedImmune is dedicated to conducting ground-breaking research on the prevention of respiratory syncytial virus (RSV) and influenza in...

2009-10-30 10:56:00

PHILADELPHIA, Oct. 30 /PRNewswire/ -- MedImmune announced today it will present four abstracts at the 47th Annual Meeting of Infectious Disease Society of America (IDSA) being held here October 29 through November 1, 2009. These abstracts advance the body of data surrounding respiratory syncytial virus (RSV) and influenza prevention, highlighting MedImmune's leadership in pediatric health. "MedImmune is dedicated to conducting ground-breaking research on the prevention of respiratory...